Lysosomal acid lipase (LAL) hydrolyzes cholesteryl esters (CEs) and triglycerides (TGs) to free cholesterol (FC) and free fatty acids (FFAs), which are then used for metabolic purposes in the cell. The process also occurs in immune cells that adapt their metabolic machinery to cope with the different energetic requirements associated with cell activation, proliferation, and polarization. LAL deficiency (LALD) causes severe lipid accumulation and affects the immunometabolic signature in animal models. In humans, LAL deficiency is associated with a peculiar clinical immune phenotype, secondary hemophagocytic lymphohistiocytosis. These observations suggest that LAL might play an important role in cellular immunometabolic modulation, and availability of an effective enzyme replacement strategy makes LAL an attractive target to rewire the metabolic machinery of immune cells beyond its role in controlling cellular lipid metabolism.
Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target / M. Gomaraschi, F. Bonacina, G.D. Norata. - In: TRENDS IN PHARMACOLOGICAL SCIENCES. - ISSN 0165-6147. - 40:2(2019 Feb), pp. 104-115. [10.1016/j.tips.2018.12.006]
Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target
M. GomaraschiPrimo
;F. BonacinaSecondo
;G.D. Norata
Ultimo
2019
Abstract
Lysosomal acid lipase (LAL) hydrolyzes cholesteryl esters (CEs) and triglycerides (TGs) to free cholesterol (FC) and free fatty acids (FFAs), which are then used for metabolic purposes in the cell. The process also occurs in immune cells that adapt their metabolic machinery to cope with the different energetic requirements associated with cell activation, proliferation, and polarization. LAL deficiency (LALD) causes severe lipid accumulation and affects the immunometabolic signature in animal models. In humans, LAL deficiency is associated with a peculiar clinical immune phenotype, secondary hemophagocytic lymphohistiocytosis. These observations suggest that LAL might play an important role in cellular immunometabolic modulation, and availability of an effective enzyme replacement strategy makes LAL an attractive target to rewire the metabolic machinery of immune cells beyond its role in controlling cellular lipid metabolism.File | Dimensione | Formato | |
---|---|---|---|
Manuscript. TIPS-D-18-00176_R1 CLEAN.pdf
accesso aperto
Tipologia:
Pre-print (manoscritto inviato all'editore)
Dimensione
151.87 kB
Formato
Adobe PDF
|
151.87 kB | Adobe PDF | Visualizza/Apri |
1-s2.0-S0165614718302311-main (1).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.65 MB
Formato
Adobe PDF
|
1.65 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.